Multidisciplinary group (managers, specialists in information analysis, economists, statisticians, clinicians and engineers) which aims to improve the management and clinical practice of the hospital through the generation of scientific evidence in the areas of healthcare organization, provision of care and its results for patients, and research into strategies to promote responsible research with an impact on clinical practice. In 2022, the group has had 29 members and 17 publications have been generated in journals with impact factor, of which 9 are in the first quartile. Throughout 2022, the following areas were addressed: 1) Evaluation of health services and interventions in terms of effectiveness, quality, safety and costs, 2) Research into new models of information management and digital transformation in health, 3) Development and evaluation of an open and collaborative innovation model, 4) Valorization and technological transfer as a generator of social and economic wealth

Group Leader
Albert Salazar i Soler

Researchers
Maria Jose Abadias Medrano, Marta Aguayo Álvarez, Cynthia Ana Alegre Miranda, Daniel Andres Esobedo, Mª Ángeles Barba Flores, Yolima Cossio Gil, José Manuel Domínguez González, Guillermo Andres Fernández Olivares, Gloria M Gálvez Hernando, Emmanuel Giménez García, Maria Gutiérrez-San Miguel Guilera, César Llorente Parrado, Sara López Branchadell, Susana Malgrat Caballero, Luis Jose Marte Fernández, Roser Martin Campos, Montse Martinez Muñoz, Jesús Martínez Pérez, Rosa Mejon Berges, Dimelza Osorio Sánchez, Percy Efrain Pantoja Bustillos, Rosa Ramos Sánchez, Soledad Romea Lecumberri, Maria Rosa Romero Suau, Karla Salas Gama, Albert Salazar i Soler, Julia Salvador Lodosa, Lynn Seveke, Victoria Valls Comamala

13

PUBLICATIONS

61.5%

%Q1

79

IMPACT FACTOR

6.04

AVERAGE IMPACT FACTOR

SELECTED ARTICLES

Ribera A, Gimenez E, Oristrell G, Osorio D, Marsal JR, Garcia-Perez L, Ballesteros M, Rodenas E, Belahnech Y, Escalona R, Rivas N, Roca-Luque I, Ferreira-Gonzalez I, Espallargues M
Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
Rev Esp Cardiol. 2022 Jan;75(1):12-21. doi: 10.1016/j.rec.2021.05.004. Epub 2021 Jun 5.
DOI: doi: 10.1016/j.rec.2021.05.004
IF: 7.05

Allen A, Patrick H, Ruof J, Buchberger B, Varela-Lema L, Kirschner J, Braune S, Rossnagel F, Gimenez E, Cusco XG, Guilhaume C
Development and Pilot Test of the Registry Evaluation and Quality Standards Tool: An Information Technology-Based Tool to Support and Review Registries.
Value Health. 2022 Aug;25(8):1390-1398. doi: 10.1016/j.jval.2021.12.018. Epub 2022 Mar 8.
DOI: doi: 10.1016/j.jval.2021.12.018
IF: 5.16

Salas-Gama K, Onakpoya IJ, Coronado Daza J, Perera R, Heneghan CJ
Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: A systematic review.
PLoS One. 2022 Jun 13;17(6):e0266202
DOI: doi: 10.1371/journal.pone.0266202
IF: 3.75

Cossio-Gil Y, Omara M, Watson C, Casey J, Chakhunashvili A, Gutierrez-San Miguel, Kahlem P, Keuchkerian S, Kirchberger V, Luce-Garnier V, Michiels D, Moro M, Philipp-Jaschek B, Sancini S, Hazelzet J, Stamm T
The Roadmap for Implementing Value-Based Healthcare in European University Hospitals-Consensus Report and Recommendations.
Value Health. 2022 Jul;25(7):1148-1156. doi: 10.1016/j.jval.2021.11.1355. Epub 2021 Dec 15.
DOI: doi: 10.1016/j.jval.2021.11.1355
IF: 5.16

Andrews MR, Long PA, Ahlberg M, Balvert F, Alessandrello R, Lazzari A, Timmermann MM, Nouri Janian M, Rantaniska M, Spence A, Soderman P, Valls-Comamala V, Stamm T
A European arena for joint innovation in healthcare: The Platform for Innovation of Procurement and Procurement of Innovation (PiPPi).
Front Public Health. 2023 Jan 12;10:1000590
DOI: doi: 10.3389/fpubh.2022.1000590
IF: 6.46

P122/00371. Desarrollo y evaluación de la implantación de una herramienta co-creada para la identificación y notificación por parte del paciente de cuasi-incidentes de seguridad en la atención hospitalaria.
Principal Investigator: Osorio Sánchez, D
Agency: Carlos III Health Institute
Funding: 62,920 €
Period: 2022-2025